NCT02388191View on ClinicalTrials.gov

Naproxen for Pain Control With Intrauterine Device Insertion

NACompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Contraception
Interventions
DRUG

Naproxen sodium

550 mg, oral, on day 1. Number of Cycles: 1

OTHER

Placebo tablet

Trial Locations (1)

02215

Planned Parenthood League of Massachusetts, Boston

All Listed Sponsors
lead

Planned Parenthood League of Massachusetts

OTHER

NCT02388191 - Naproxen for Pain Control With Intrauterine Device Insertion | Biotech Hunter | Biotech Hunter